M. Kamali et al., The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia, ACT PSYC SC, 101(6), 2000, pp. 452-456
Objective: To estimate the prevalence, and identify the clinical correlates
of comorbid substance misuse (abuse or dependence) among readmissions with
schizophrenia, particularly to establish whether comorbid substance misuse
is associated with higher rates of depressive symptoms and suicidal ideati
on.
Method: Over 12 months, consecutive readmissions from a catchment area psyc
hiatric service with DSM-IV schizophrenia/schizoaffective disorder were ass
essed using clinical assessments of symptomatology including depression, in
sight and compliance. Comorbid substance misuse was diagnosed using DSM-IV
criteria.
Results: Of 102 readmissions 40% had lifetime, while 20% had current comorb
id substance misuse and were predominately young males. Comorbid substance
misuse had no statistically significant impact on positive, negative or dep
ressive symptomatology. However, those currently misusing substances report
ed more suicidal ideation compared with past or non-substance misusers.
Conclusion: Readmissions with comorbid substance misuse were more likely to
report suicidal ideation, and may represent a group of individuals who are
at higher risk of suicide.